| Literature DB >> 27502128 |
Abstract
Endovascular therapy has become the first-line strategy for most peripheral artery disease cases. Currently, many guidelines recommend endovascular therapy as the first choice for arteriosclerosis obliterans. Recently, drug-eluting stent and drug-coated balloon are available. The clinical outcomes have been greatly improved with the evolution of devices. However, the long-term outcomes of endovascular therapy for arteriosclerosis obliterans are still not satisfied. Many centers treat arteriosclerosis obliterans using endovascular therapy in appropriately. In this editorial, an evidence-based approach and some strategies will be discussed to standardize the endovascular treatment and improve the result of endovascular therapy for arteriosclerosis obliterans.Entities:
Mesh:
Year: 2016 PMID: 27502128 DOI: 10.3760/cma.j.issn.0529-5815.2016.08.002
Source DB: PubMed Journal: Zhonghua Wai Ke Za Zhi ISSN: 0529-5815